Gracell Biotechnologies Inc.: pretax_income
| Value | {"amount": -45518000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-06-30 |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8d79e691-9e53-4995-adba-5176110092f9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-221202Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/pretax-income/2022-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8d79e691-9e53-4995-adba-5176110092f9
History
- supersedes {"unit": "CNY", "value": -304888000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"} (evidence 0001193125-22-221202)